This is the authors' abstract. We don't add key points for this paper.
Nearly a half century ago, 24-hour esophageal pH monitoring was introduced as a method to identify, in a near-physiologic setting, patients with increased esophageal acid exposure.1 It did so by measuring the frequency and duration of acid exposure to the mucosa of the esophagus. I felt a quiet sense of personal pleasure learning from the article by Neto, Herbella, Schlottmann, and Patti that 24-hour esophageal pH monitoring is still clinically useful from 44 years after its introduction in 1974. Its initial development was fostered by the disappointment in the correlation between the lower esophageal sphincter (LES) pressure and the presence of symptoms, endoscopic findings, and radiographic evidences of gastro-esophageal reflux disease (GERD). Consequently, practitioners were energized to quantify directly the amount of gastric acid that refluxed into the esophagus as a way of identifying patients with GERD. Achieving this goal was more arduous than thought. It is important to emphasize that esophageal pH monitoring is not only a test to measure esophageal acid exposure, but also when and how that exposure occurred. To make this assessment required measuring the frequency and duration of esophageal reflux episodes below the pH of 4. This pH value was chosen on the basis of the landmark studies of Bernstein and Baker, and Tuttle and Grossman, both in 1958.2,3 Bernstein and Baker were the first to recognize the relationship between the presence of acid in the esophagus and symptoms of heartburn and regurgitation. They developed an acid perfusion test to reproduce the patient's esophageal symptoms by the instillation of 0.1 N HCl acid into the esophagus. Tuttle and Grossman attempted, with minimal success, to improve on the low specificity of the Bernstein test by directly measuring intraesophageal pH at rest and after the patient performed certain reflux provoking maneuvers. In 1961, Tuttle et al.4 showed that the onset of heartburn occurred when the intra-esophageal pH dropped to a value of <4. Four years later, in 1965, Piper and Fenton5 showed that the proteolytic enzyme pepsin was activated by an intraluminal esophageal pH of <4 and induced hemorrhagic erosive esophagitis. Together these studies identified that the critical determinant of GERD was exposure of the esophageal mucosa to a pH <4. Despite this discovery, it soon became apparent that just improving the ability to detect esophageal exposure to a pH <4 was of limited value in differentiating between normal subjects and patients with symptoms of GERD. The next advance in the evolution of esophageal pH monitoring was determining where the pH electrode should be placed in the esophagus. Kantrowitz etal.6 using a motility catheter containing a pH electrode at its tip showed, by withdrawal of the catheter from the stomach into the esophagus, that the point at which the pH changed to above 4 in relation to the location of the LES was variable. A gradual rise in pH continued above the upper border of the LES before the pH of 4 was reached in most patients who had reflux symptoms; however in others there was a sharp, rapid rise in pH to above 4 that coincided with the upper border of the LES. Individuals who had no evidence of reflux symptoms also commonly exhibited a pH withdrawal that extended above the upper border of the LES before a pH of >4 were reached but rarely more than 5 cm. These studies suggested that a pH <4 more than 5 cm above the LES was more likely to be diagnostic of GERD. As a consequence, it was common for the pH electrode to be placed 5 cm above the upper LES border in subsequent studies. Initially, most investigators focused on short monitoring periods consisting of a few hours. Later, interest shifted to longer monitored periods to obviate the need to establish forced periods for eating in the upright position and sleeping in the recumbent position. Eventually, consensus emerged to monitor patients for one circadian cycle divided into day and nighttime segments. This allows analysis of the reflux pattern when awake in the upright posture before, during and after meals and when asleep in the recumbent position. To analyze the data generated, it is important to re-emphasize that 24-hour esophageal pH monitoring is not only a test for measuring esophageal acid exposure, but also how the exposure occurred by measuring the number and duration of reflux episodes. For this reason, Dr. Johnson and I measured esophageal exposure to a pH <4 using six different components of the pH record: (1) the percent time the pH was <4 for the total monitored period, (2) for the time spent in the upright position, and (3) for the time spent in the supine position, (4) the total number of reflux episodes, (5) the number of episodes that lasted longer than 5 minutes, and (6) the duration of the longest episode.1,7 These are the six measured components of the 24-hour record. A component was abnormal if its recorded measurement exceeded the mean value plus two standard deviations of the same component measured in a control group of normal subjects. This definition was chosen since statistically 95% of the control group had values for each parameter that fell into a normal distribution pattern. However, when this definition of abnormality was applied to a patient population with typical symptoms of GERD, the six components were not uniformly sensitive. This observation showed that patients with GERD did not have a homogeneous pattern of reflux. It also indicated the need for the six components to define collectively a single value above which esophageal acid exposure was globally abnormal. To solve this problem, the standard deviation for each component in the asymptomatic volunteer control group became the scoring unit for that particular component. This scoring unit was divided into the patient's value for that component in order to award points. This allowed the awarding of points in accordance with the ability of that component to define abnormality. Hence, using the standard deviation of each component as a scoring unit allows the data from normal subjects to score the pH record of symptomatic patients in a manner weighted to their departure from physiologic reflux. In order to use the standard deviation as the scoring unit, a zero point had to be established for each component. This was accomplished by assigning zero as two standard deviations below the mean value of that particular component in the volunteer control group (Fig. 1). Using this concept, the new zero point for the scoring system would be equitable among the six components even though their mean values and standard deviations varied. A pH composite score for a patient was determined by adding the points from each of the six components. An abnormal pH composite score was defined as one that exceeded the mean and two standard deviations above the pH composite score calculated for the asymptomatic control group. Although the process appears quite complex it has been simplified by electronics, is applicable to both catheter8 and catheter-free9 monitoring and has stood the test of time as the article by Herbella and associates points out. An illustration of the concept of using the standard deviation calculated for each of the six components of the pH score measured in 50 control subject as the scoring unit to express acid exposure. To do so require designating a zero point for each component two standard deviations below the mean value measured for each of the six components in the control group. The illustration shows the establishment of zero two standard deviations below the mean value for the total period of acid exposure. Note also the establishment of the patient's score of 4.41 for total esophageal acid exposure based on the number of scoring units obtained for the component of total percent time the pH was <4. Adding the score units from each of the patient's six components provides the pH composite score. The Bravo pH capsule was introduced as a catheter-free system for ambulatory esophageal pH monitoring with improved patient comfort allowing the measurement of esophageal pH over 48 hours or longer. A dilemma can arise when performing pH monitoring for two successive days in that 24–32% of patients will have abnormal esophageal acid exposure detected on only 1 of the 2 days. The reason for the discrepancy was an enigma until the following study was carried out. Bravo pH monitoring was performed by transnasal manometric placement of the capsule 5 cm above the proximal LES border in 310 patients. The patients were divided into groups based on their 24-hour composite pH score; both days normal, both days abnormal, and only 1 of the 2 days abnormal. LES characteristics were compared between the groups. Of the 310 patients, 127 had a normal pH score on both days, 123 had an abnormal pH score on both days and 60 (19%) had a discrepancy between the 2 days. Patients with abnormal esophageal acid exposure on both days had higher esophageal acid exposure and a higher incidence of a defective LES compared to those with an abnormal pH score on only 1 day (35 vs. 83%, p = 0.027). Consequently patients who had a discrepancy between days of Bravo pH monitoring have less deterioration of the LES indicating earlier reflux disease with day to day variability, while those who were abnormal on both days had more deterioration of the LES indicating more advanced disease with consistent day to day reflux.10 Clinical experience has shown a difference in the esophageal acid exposures measured in normal subjects depending on the technique used to positioned the Brave pH capsule; placing the capsule 6 cm above the squamo-columnar junction measured by endoscopy or placing the capsule 5 cm above the upper border of the LES measured by manometry. Studies have shown that the endoscopic placement is a median of 2 cm shorter than the manometric placement.11 Further, studies have shown considerable differences in esophageal acid exposure when recording sites are placed at various levels within the 5 cm above the upper LES border. For example, the esophageal acid exposure at 1.5 cm above the upper LES border is significantly higher (12.7% pH < 4) than when recorded at the standard location of 5 cm above the upper LES border (3.4% pH < 4)(p < 0.01).12 This makes the level of capsule placement methodologically crucial. There are three explanations for this difference, all of which make the endoscopic placement of the Bravo pH capsule subject to error. First, there is variability in the position of the squamo-columnar junction in relationship to the LES in normal subjects and patients with GERD. Second, there is a median variability of 2 cm when attempting to place a Bravo pH capsule 5 cm above the upper border of the LES using a peroral endoscope and measuring 6 cm above the squamocolumnar junction. Third, there is a seven-fold increase in esophageal acid exposure between a point 5 cm above and down to the upper border of the LES.12 Consequently, as the upper LES border is approached the higher the esophageal acid exposure becomes, emphasizing that small errors in the placement of the pH sensor can significantly affect the results of pH monitoring. Thus, a pH sensors of any type, if placed too low in the esophagus, may result in the over diagnosis of GERD and if placed too high may result in the failure to diagnose GERD. After 44 years of esophageal pH monitoring we are beginning to realize that there is considerable intraluminal acid exposure within the LES. Studies of normal subjects have shown that intra-LES pH values recorded at 0, 1.5, 3.0, and 4.5 cm distal to the upper border of the LES have a pH < 4 of 26.5%, 48.1%, 66.5%, and 80.8% of the 24-hour pH monitoring period, respectively.12 We have come to understand that this manometrically defined high pressure area at the gastroesophageal junction (LES) has a high acid exposure. Additionally, the distal-most esophagus, which is lined by stratified squamous epithelium, extends into this manometrically defined high pressure area for 1.5 to 2 cm and is exposed to acid 26–66% of the day in normal subjects.12 This is an 8-to 20-fold increase in acid exposure time compared to the traditional distal esophageal recording site 5 cm above the upper LES border. It is possible that this short segment of distal esophagus lined by stratified squamous mucosa and extends into the LES can develop erosive esophagitis, a Schatzki ring, a distal esophageal stricture, a short-segment Barrett's esophagus, and esophageal adenocarcinoma.13 We are just beginning to recognize that this intrasphincteric disease can be void of the usual GERD symptoms of substernal heartburn and regurgitation. Subsequent clinical studies will require that trans-sphincteric pH profiles be recorded in these patients using pH probes that can be appropriately anchored within the LES to prevent movement of the pH electrode and allow the measurement of intra-sphincteric acidity. The author declares no conflict of interest.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tom R. DeMeester (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: